Table 1 Clinical data of the patients.

From: Usefulness of heart rhythm complexity in heart failure detection and diagnosis

 

HF (N = 55)

Control (N = 97)

P Value

Age (years)

61 ± 14

59 ± 11

0.215

Male, n (%)

43 (78%)

65 (67%)

0.144

CAD, n (%)

41 (74)

9 (9%)

 < 0.001

DM, n (%)

23 (42%)

23 (24%)

0.020

HTN, n (%)

31 (56%)

63 (65%)

0.295

Dyslipidemia, n (%)

15 (27%)

18 (19%)

0.08

Medication

ACEI/ARB

44 (80%)

32 (33%)

 < 0.001

Beta-blocker

39 (71%)

46 (47%)

0.005

CCB

9 (16%)

31 (32%)

0.036

Glucose AC, mg/dL

118 ± 38

100 ± 17

0.002

Creatinine, mg/dL

1.6 ± 1.5

0.93 ± 0.20

0.002

ALT

35 ± 43

24 ± 10

0.125

TG, mg/dL

151 ± 99

131 ± 68

0.192

T-Chol, mg/dL

181 ± 38

173 ± 36

0.239

LVEF, %

35 ± 9.4

70 ± 5.6

 < 0.001

LVEDD, mm

60 ± 9.6

47 ± 3.8

 < 0.001

LVESD, mm

50 ± 9.7

28 ± 3.0

 < 0.001

  1. Data were presented as mean ± standard deviation or number (percentage).
  2. CAD coronary artery disease, DM diabetes mellitus, HTN hypertension, ACEI Angiotensin-converting enzyme inhibitors, ARB angiotensin receptor blockers, CCB calcium channel blocker, TG triglyceride, T-Chol total cholesterol, LVEF left ventricular ejection fraction, LVEDD left ventricular end-diastolic diameter, LVESD left ventricular end-systolic diameter.
Back to article page